1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Anavex Life Sciences Corporation (AVXL)
  7. Quote


Anavex Life Sciences Stock Price

0.46 (2.42%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 794,878
Bid Price 19.56
Ask Price 19.85
News -
Day High 19.9499


52 Week Range


Day Low 18.10
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Anavex Life Sciences Corporation AVXL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.46 2.42% 19.45 17:00:00
Open Price Low Price High Price Close Price Prev Close
18.21 18.10 19.9499 19.45 18.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,397 794,878 $ 19.20 $ 15,262,102 - 4.515 - 31.50
Last Trade Time Type Quantity Stock Price Currency
16:54:04 formt 150 $ 19.85 USD


Draw Mode:

Anavex Life Sciences Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.47B 75.71M 73.31M $ - $ - -0.45 -39.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 665.00k 13.40%

more financials information »

Anavex Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AVXL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week20.0021.3017.3718.871,080,740-0.55-2.75%
1 Month18.1823.7317.3720.88854,7041.276.99%
3 Months19.8723.7316.54518.97775,559-0.42-2.11%
6 Months11.1031.5011.1021.221,762,0608.3575.23%
1 Year5.1931.504.51516.092,141,42714.26274.76%
3 Years2.3631.501.2511.351,155,02717.09724.15%
5 Years4.0031.501.259.92868,22215.45386.25%

Anavex Life Sciences Description

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2.

Your Recent History
Anavex Lif..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.